Anne-Marie Mes-Masson

Anne-Marie Mes-Masson

UNVERIFIED PROFILE

Are you Anne-Marie Mes-Masson?   Register this Author

Register author
Anne-Marie Mes-Masson

Anne-Marie Mes-Masson

Publications by authors named "Anne-Marie Mes-Masson"

Are you Anne-Marie Mes-Masson?   Register this Author

100Publications

2885Reads

50Profile Views

Ran GTPase: A Key Player in Tumor Progression and Metastasis.

Front Cell Dev Biol 2020 26;8:345. Epub 2020 May 26.

Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Montreal, QC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fcell.2020.00345DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7264121PMC
May 2020

Comparison and Analysis of Two Internationally Recognized Biobanking Standards.

Biopreserv Biobank 2020 Apr 27;18(2):82-89. Epub 2020 Jan 27.

Office of Biobank Education and Research, Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/bio.2019.0126DOI Listing
April 2020

Distinct Histologic, Immunohistochemical and Clinical Features Associated With Serous Endometrial Intraepithelial Carcinoma Involving Polyps.

Int J Gynecol Pathol 2020 Mar;39(2):128-135

Department of Pathology (V.Q.-H.T., M.P.P., F.G., K.R.) Department of Obstetrics and Gynecology, Division of Gynecologic Oncology (T.W., P.S., D.M.P.), University of Montreal Health Center Department of Medicine (A.-M.M.-M.), University of Montreal Research Center of the University of Montreal Health Center (V.Q.-H.T., P.E., T.W., P.S., F.G., A.-M.M.-M., D.M.P., K.R.), Montreal, Quebec, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PGP.0000000000000591DOI Listing
March 2020

Clinicopathological features of women with epithelial ovarian cancer and double heterozygosity for BRCA1 and BRCA2: A systematic review and case report analysis.

Gynecol Oncol 2020 02 18;156(2):377-386. Epub 2019 Nov 18.

Centre de recherche du Centre hospitalier de l'Université de Montreal (CRCHUM), and Institut du cancer de Montréal, Montreal, QC, Canada; Department of Medicine, University of Montreal, Montreal, QC, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2019.11.019DOI Listing
February 2020

Exploring the Clinical Impact of Predictive Biomarkers in Serous Ovarian Carcinomas.

Curr Drug Targets 2020 ;21(10):974-995

Centre de recherche du Centre hospitalier de l'Universite de Montreal (CRCHUM) and Institut du cancer de Montreal, Montreal, QC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/1389450120666191016143836DOI Listing
January 2020

Canadian Tissue Repository Network Biobank Certification Program: Update and Review of the Program from 2011 to 2018.

Biopreserv Biobank 2019 Dec 13;17(6):530-538. Epub 2019 Jun 13.

Biobanking and Biospecimen Research Services, Deeley Research Centre, British Columbia Cancer-Victoria Center, Victoria, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/bio.2019.0015DOI Listing
December 2019

Pre-operative Circulating Plasma Gelsolin Predicts Residual Disease and Detects Early Stage Ovarian Cancer.

Sci Rep 2019 09 26;9(1):13924. Epub 2019 Sep 26.

Departments of Obstetrics & Gynecology and Cellular & Molecular Medicine, University of Ottawa, Ottawa, K1H 8L1, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41598-019-50436-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6763481PMC
September 2019

A COEUR cohort study of SATB2 expression and its prognostic value in ovarian endometrioid carcinoma.

J Pathol Clin Res 2019 07 20;5(3):177-188. Epub 2019 Apr 20.

Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM) and Institut du Cancer de Montréal, Montreal, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cjp2.131DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6648975PMC
July 2019

CCN3/Nephroblastoma Overexpressed Is a Functional Mediator of Prostate Cancer Bone Metastasis That Is Associated with Poor Patient Prognosis.

Am J Pathol 2019 07 12;189(7):1451-1461. Epub 2019 Jun 12.

Goodman Cancer Research Centre, Department of Medicine, McGill University, Montréal, Québec, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajpath.2019.04.006DOI Listing
July 2019

Ran promotes membrane targeting and stabilization of RhoA to orchestrate ovarian cancer cell invasion.

Nat Commun 2019 06 17;10(1):2666. Epub 2019 Jun 17.

Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montreal, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41467-019-10570-wDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6573066PMC
June 2019

Long-term fluorescence hyperspectral imaging of on-chip treated co-culture tumour spheroids to follow clonal evolution.

Integr Biol (Camb) 2019 04;11(4):130-141

Polytechnique Montréal, Department of Engineering Physics and Institute of Biomedical Engineering, Montreal, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/intbio/zyz012DOI Listing
April 2019

Prognostic value of progesterone receptor expression in tubo-ovarian high-grade serous carcinoma of the COEUR cohort.

Histopathology 2019 03 15;74(4):663-666. Epub 2019 Jan 15.

Department of Pathology and Laboratory Medicine, Foothills Medical Center, University of Calgaryf, Calgary, Alberta, Canada.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/his.13784
Publisher Site
http://dx.doi.org/10.1111/his.13784DOI Listing
March 2019

Fluorescence hyperspectral imaging for live monitoring of multiple spheroids in microfluidic chips.

Analyst 2018 Aug;143(16):3829-3840

Department of Engineering Physics, Polytechnique Montréal, C.P. 6079, Succ. Centre-ville, Montreal, Qc H3C 3A7, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1039/c8an00536bDOI Listing
August 2018

Describing perspectives of health care professionals on active surveillance for the management of prostate cancer.

BMC Health Serv Res 2018 06 8;18(1):430. Epub 2018 Jun 8.

Institut du cancer de Montréal and Centre de recherche du Centre hospitalier de l'Université de Montréal, 900, St Denis St, Montréal, QC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12913-018-3273-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5994022PMC
June 2018

The Canadian Partnership for Tomorrow Project: a pan-Canadian platform for research on chronic disease prevention.

CMAJ 2018 06;190(23):E710-E717

School of Population and Public Health (Dummer), University of British Columbia, Vancouver, BC; Ontario Institute for Cancer Research (Awadalla); CARTaGENE (Boileau), Montréal, Que.; Research Institute of the McGill University Health Centre (Craig, Fortier); Research and Innovation, University of Toronto (Goel); Ontario Agency for Health Protection and Promotion (Goel); Atlantic PATH, Dalhousie University (Hicks), Halifax, NS; Centre hospitalier universitaire Sainte-Justine (Jacquemont); Centre of Genomics and Policy, McGill University (Knoppers, Zawati), Montréal, Que.; BC Cancer Research Centre (Le, McDonald), Vancouver, BC; Public Health Ontario (McLaughlin), Toronto, Ont.; Institut du cancer de Montréal, Université de Montréal (Mes-Masson); Pediatrics, CHU Sainte-Justine Research Center (Nuyt), Montréal, Que.; School of Public Health, University of Adelaide (Palmer), Adelaide, Australia; Department of Medicine, Dalhousie University (Parker); Division of Cancer Epidemiology and Genetics, National Cancer Institute (Purdue), Bethesda, Md.; CancerControl Alberta, Alberta Health Services (Robson, Vena), Edmonton, Alta.; Population Oncology, BC Cancer (Spinelli), Vancouver, BC; Atlantic PATH, Dalhousie University (Thompson), Halifax, NS.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1503/cmaj.170292DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5995593PMC
June 2018

Hormonal and reproductive factors and the risk of ovarian cancer.

Cancer Causes Control 2017 May 19;28(5):393-403. Epub 2017 Jan 19.

Université de Montréal Hospital Research Centre (CRCHUM), 850 Saint-Denis Street, 2nd Floor, Montreal, QC, H2X 0A9, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10552-016-0848-9DOI Listing
May 2017

Microcystic, elongated, and fragmented pattern invasion is mainly associated with isolated tumor cell pattern metastases in International Federation of Gynecology and Obstetrics grade I endometrioid endometrial cancer.

Hum Pathol 2017 04 15;62:33-39. Epub 2016 Nov 15.

Department of Pathology, Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada H2L 4M1; Department of Pathology and Cellular Biology, Université de Montréal, Montreal, Quebec, Canada H3T 1J4; Centre de Recherche du Centre Hospitalier de l'Université de Montréal and Institut du Cancer de Montréal, Montreal, Quebec, Canada H2X 0A9. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humpath.2016.10.023DOI Listing
April 2017

Roles for APRIN (PDS5B) in homologous recombination and in ovarian cancer prediction.

Nucleic Acids Res 2016 12 24;44(22):10879-10897. Epub 2016 Oct 24.

Genome Stability Laboratory, CHU de Québec Research Center, HDQ Pavilion, Oncology Axis, 9 McMahon, Québec City, QC G1R 2J6, Canada

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/nar/gkw921DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5159559PMC
December 2016

Optimized p53 immunohistochemistry is an accurate predictor of mutation in ovarian carcinoma.

J Pathol Clin Res 2016 Oct 13;2(4):247-258. Epub 2016 Jul 13.

Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre Cambridge CB2 0RE UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cjp2.53DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5091634PMC
October 2016

STAT1-associated intratumoural T1 immunity predicts chemotherapy resistance in high-grade serous ovarian cancer.

J Pathol Clin Res 2016 Oct 19;2(4):259-270. Epub 2016 Sep 19.

Department of Biomedical and Molecular SciencesQueen's UniversityKingstonOntarioK7L 3N6Canada; Department of Obstetrics and GynecologyKingston General HospitalKingstonOntarioK7L 3N6Canada; Cancer Biology and Genetics DivisionQueen's Cancer Research Institute, Queen's UniversityOntarioK7L 3N6Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cjp2.55DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5129574PMC
October 2016

An Immunohistochemical Algorithm for Ovarian Carcinoma Typing.

Int J Gynecol Pathol 2016 Sep;35(5):430-41

Calgary Laboratory Services/Alberta Health Services (M.K., P.F.R., C.N., S.L.), Department of Pathology and Laboratory Medicine, Foothill Medical Center, University of Calgary, Calgary Department of Laboratory Medicine and Pathology (X.L., C.A.E., C.-H.L.), University of Alberta, Edmonton, AB Centre de recherche du (K.R., C.L.P., L.M., M.d.L., D.P., A.-M.M.M.), Centre hospitalier de l'Université de Montréal (CRCHUM) Departments of Pathology (K.R.) Obstetric-Gynecology (D.P.) Medicine (A.-M.M.M.), Université de Montréal Institut du cancer de Montréal (C.L.P., L.M., M.d.L., D.P., A.-M.M.M.), Montreal, QC Department of Pathology (S.L., D.H., C.B.G.), University of British Columbia, Vancouver, BC Department of Cellular and Molecular Medicine (B.V.), University of Ottawa, ON, Canada Department of Pathology (P.F.R.), Catholic University of Health and Allied Sciences-Bugando, Mwanza, Tanzania Department of Health Sciences Research (E.L.G.), Mayo Clinic, Rochester, Minnesota Department of Preventive Medicine (S.J.R.), Keck School of Medicine, USC/Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California Department of Pathology and Cytology (J.W.C.), Institution for Oncology-Pathology, Karolinska University Hospital, Stockholm, Sweden Department of Public Health Sciences (L.E.K.), College of Medicine, Medical University of South Carolina Hollings Cancer Center (L.E.K.), Medical University of South Carolina, Charleston, South Carolina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PGP.0000000000000274DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4978603PMC
September 2016

Robust high-performance nanoliter-volume single-cell multiple displacement amplification on planar substrates.

Proc Natl Acad Sci U S A 2016 07 13;113(30):8484-9. Epub 2016 Jul 13.

Michael Smith Laboratories, University of British Columbia, Vancouver, BC, Canada V6T 1Z4; Department of Physics and Astronomy, University of British Columbia, Vancouver, BC, Canada V6T 1Z4

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.1520964113DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4968760PMC
July 2016

Calibration and Optimization of p53, WT1, and Napsin A Immunohistochemistry Ancillary Tests for Histotyping of Ovarian Carcinoma: Canadian Immunohistochemistry Quality Control (CIQC) Experience.

Int J Gynecol Pathol 2016 May;35(3):209-21

Department of Pathology and Laboratory Medicine (S.L., W.C., P.E.S., M.K.), University of Calgary, Calgary, ABCentre de recherche du (C.L.P., A.-M.M.M.), Centre hospitalier de l'Université de Montréal (CRCHUM), Institut du cancer de MontréalDepartment of Medicine (D.P., D.H.), Université de Montréal, Montreal, QCDepartment of Pathology (C.B.G.), University of British Columbia, Vancouver, BC, CanadaFunctional Genomics and Ovarian Cancer Laboratory (A.P.), Li Ka Shing Centre, Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PGP.0000000000000251DOI Listing
May 2016

Potential Cross-Talk between Alternative and Classical NF-κB Pathways in Prostate Cancer Tissues as Measured by a Multi-Staining Immunofluorescence Co-Localization Assay.

PLoS One 2015 17;10(7):e0131024. Epub 2015 Jul 17.

Institut du cancer de Montréal / Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), 900 rue St-Denis, Montreal, Canada; Division of Urology, CHUM and Department of Surgery, Université de Montréal, Montreal, Canada.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0131024PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4505937PMC
April 2016

The human organic cation transporter OCT1 mediates high affinity uptake of the anticancer drug daunorubicin.

Sci Rep 2016 Feb 10;6:20508. Epub 2016 Feb 10.

Maisonneuve-Rosemont Hospital, Research Center, Université de Montréal, Department of Medicine, 5415 Boul. de l' Assomption, Montréal, Québec, Canada, H1T 2M4.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/srep20508DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4748219PMC
February 2016

RAN nucleo-cytoplasmic transport and mitotic spindle assembly partners XPO7 and TPX2 are new prognostic biomarkers in serous epithelial ovarian cancer.

PLoS One 2014 13;9(3):e91000. Epub 2014 Mar 13.

Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Montreal, Canada; Institut du Cancer de Montréal, Montreal, Canada; Department of Medicine, Université de Montréal, Montreal, Canada.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0091000PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3953127PMC
January 2016

PRP4K is a HER2-regulated modifier of taxane sensitivity.

Cell Cycle 2015 ;14(7):1059-69

a Department of Biochemistry & Molecular Biology ; Dalhousie University ; Halifax , NS Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/15384101.2015.1007775DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4612451PMC
December 2015

CD73 is associated with poor prognosis in high-grade serous ovarian cancer.

Cancer Res 2015 Nov 11;75(21):4494-503. Epub 2015 Sep 11.

Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Québec, Canada. Institut du Cancer de Montréal, Montréal, Québec, Canada. Faculté de Pharmacie, Université de Montréal, Québec, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-14-3569DOI Listing
November 2015

Chemotherapy reduces PARP1 in cancers of the ovary: implications for future clinical trials involving PARP inhibitors.

BMC Med 2015 Sep 9;13:217. Epub 2015 Sep 9.

Lady Davis Institute for Medical Research, Jewish General Hospital, 3755 Côte Ste, Catherine Road, Montréal, QC, H3T 1E2, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12916-015-0454-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4565010PMC
September 2015

The ARID1A pathway in ovarian clear cell and endometrioid carcinoma, contiguous endometriosis, and benign endometriosis.

Int J Gynaecol Obstet 2015 Jul 11;130(1):27-30. Epub 2015 Apr 11.

Centre de Recherche du Centre hospitalier de l'Université de Montréal and the Institut du Cancer de Montréal, Montréal, QC, Canada; Department of Medicine, Université de Montréal, Montréal, QC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijgo.2015.02.021DOI Listing
July 2015

DNA damage signaling and apoptosis in preinvasive tubal lesions of ovarian carcinoma.

Int J Gynecol Cancer 2015 Jun;25(5):761-9

*Centre de Recherche du Centre hospitalier de l'Université de Montréal; †Institut du Cancer de Montréal, Montreal, Quebec, Canada; ‡Department of Gynecology, Hôpital Femme Mère Enfant, Hospices Civils de Lyon, Bron, France; Departments of §Pathology, and ∥Gynecology, Centre hospitalier de l'Université de Montréal, Montreal, Quebec, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/IGC.0000000000000196DOI Listing
June 2015

Double PALB2 and BRCA1/BRCA2 mutation carriers are rare in breast cancer and breast-ovarian cancer syndrome families from the French Canadian founder population.

Oncol Lett 2015 Jun 20;9(6):2787-2790. Epub 2015 Apr 20.

Department of Human Genetics, McGill University, Montreal, QC H3G1A4, Canada ; Research Institute of The McGill University Health Centre, Montreal, QC H3G1A4, Canada ; Department of Medicine, McGill University, Montreal, QC H3G1A4, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/ol.2015.3123DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4473670PMC
June 2015

Germline TP53 mutational spectrum in French Canadians with breast cancer.

BMC Med Genet 2015 Apr 12;16:24. Epub 2015 Apr 12.

Cancer Research Program, The Research Institute of the McGill University Health Centre, 1001 Decarie Boulevard, E02.6217, Montreal, Quebec, H4A 3J1, Canada.

View Article

Download full-text PDF

Source
http://bmcmedgenet.biomedcentral.com/articles/10.1186/s12881
Publisher Site
http://dx.doi.org/10.1186/s12881-015-0169-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4436120PMC
April 2015

The RelB alternative NF-kappaB subunit promotes autophagy in 22Rv1 prostate cancer cells in vitro and affects mouse xenograft tumor growth in vivo.

Cancer Cell Int 2014 28;14:67. Epub 2014 Jul 28.

Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM)/Institut du cancer de Montréal, Montreal, Canada ; Department of Medicine, Université de Montréal, Montreal, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1475-2867-14-67DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4364035PMC
March 2015

A practical tool for modeling biospecimen user fees.

Biopreserv Biobank 2014 Aug;12(4):234-9

1 University of British Columbia Office of Biobank Education and Research , Vancouver, British Columbia, Canada .

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/bio.2014.0008DOI Listing
August 2014

Establishment of primary cultures from ovarian tumor tissue and ascites fluid.

Methods Mol Biol 2013 ;1049:323-36

Campbell Family Cancer Research Institute, Ontario Cancer Institute, University Health Network, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-1-62703-547-7_24DOI Listing
March 2014

Empirical chemosensitivity testing in a spheroid model of ovarian cancer using a microfluidics-based multiplex platform.

Biomicrofluidics 2013 10;7(1):11805. Epub 2013 Jan 10.

Centre de recherche du Centre hospitalier de l'Université de Montréal and Institut du cancer de Montréal, Montréal, Québec H2L 4M1, Canada ; Département de médecine, Université de Montréal, Montréal, Québec H3T 1J4, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1063/1.4774309DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3555942PMC
January 2014

Large-scale independent validation of the nuclear factor-kappa B p65 prognostic biomarker in prostate cancer.

Eur J Cancer 2013 Jul 28;49(10):2441-8. Epub 2013 Mar 28.

Centre de recherche du Centre hospitalier de l'Université de Montréal, Institut du cancer de Montréal, and Faculty of Medicine, Université de Montréal, Montréal, Québec, Canada.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S095980491300158
Publisher Site
http://dx.doi.org/10.1016/j.ejca.2013.02.026DOI Listing
July 2013

Gata3 antagonizes cancer progression in Pten-deficient prostates.

Hum Mol Genet 2013 Jun 20;22(12):2400-10. Epub 2013 Feb 20.

Goodman Cancer Research Centre and Department of Biochemistry, McGill University, Montreal, Quebec, Canada H3A 1A3.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/hmg/ddt088DOI Listing
June 2013

Low expression of the X-linked ribosomal protein S4 in human serous epithelial ovarian cancer is associated with a poor prognosis.

BMC Cancer 2013 Jun 22;13:303. Epub 2013 Jun 22.

Centre de Recherche en Cancérologie de l'Université Laval, Hôpital Hôtel-Dieu de Québec, Quebec City, QC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2407-13-303DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3708827PMC
June 2013

Stimulation of Wnt/ß-catenin pathway in human CD8+ T lymphocytes from blood and lung tumors leads to a shared young/memory phenotype.

PLoS One 2012 30;7(7):e41074. Epub 2012 Jul 30.

Research Centre, Centre Hospitalier de l'Université de Montréal, Université de Montréal and Institut du Cancer de Montréal, Hôpital Notre-Dame, Montréal, Québec, Canada.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0041074PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3408435PMC
April 2013

Analysis of genomic abnormalities in tumors: a review of available methods for Illumina two-color SNP genotyping and evaluation of performance.

Cancer Genet 2013 Apr 25;206(4):103-15. Epub 2013 Apr 25.

Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cancergen.2013.03.001DOI Listing
April 2013

FKBP10/FKBP65 expression in high-grade ovarian serous carcinoma and its association with patient outcome.

Int J Oncol 2013 Mar 23;42(3):912-20. Epub 2013 Jan 23.

Research Centre of the University of Montreal Hospital Centre/Montreal Cancer Institute, Montreal, QC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/ijo.2013.1797DOI Listing
March 2013

Chromosome 17q25 genes, RHBDF2 and CYGB, in ovarian cancer.

Int J Oncol 2012 Jun 14;40(6):1865-80. Epub 2012 Feb 14.

Department of Human Genetics, McGill University, Montreal, Quebec, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/ijo.2012.1371DOI Listing
June 2012

Necdin, a p53-target gene, is an inhibitor of p53-mediated growth arrest.

PLoS One 2012 15;7(2):e31916. Epub 2012 Feb 15.

Centre de recherche du Centre hospitalier de l'Université de Montréal and Institut du cancer de Montréal, Montréal, Québec, Canada.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0031916PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3280226PMC
June 2012

Combination of serum biomarkers to differentiate malignant from benign ovarian tumours.

J Obstet Gynaecol Can 2012 Jun;34(6):567-574

Lady Davis Institute for Medical Research, Montreal QC; Division of Gynecologic Oncology, Jewish General Hospital, McGill University, Montreal QC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1701-2163(16)35273-2DOI Listing
June 2012

Necdin modulates proliferative cell survival of human cells in response to radiation-induced genotoxic stress.

BMC Cancer 2012 Jun 12;12:234. Epub 2012 Jun 12.

Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Institut du cancer de Montréal, Y-4606, 1560, rue Sherbrooke Est, Montréal, QC, H2L 4 M1, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2407-12-234DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3495902PMC
June 2012

Crk adaptor proteins act as key signaling integrators for breast tumorigenesis.

Breast Cancer Res 2012 May 8;14(3):R74. Epub 2012 May 8.

Department of Biochemistry, McGill University, Rosalind and Morris Goodman Cancer Research Centre, 3655 Promenade Sir William Osler, Montréal, QC H3G 1Y6, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/bcr3183DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3446336PMC
May 2012